https://gutpathogens.biomedcentral.com/articles/10.1186/s13099-020-00385-2
How to boost the immune defence prior to respiratory virus infections with the special focus on coronavirus infections
隻看題目便知，是在感染病毒之前用的
有幾篇日本研究文章，用的是特殊途徑合成的beta-glucan, 不是市麵常見的1，3或1,6-鍵。 這類由廠家直接讚助的研究，其目的性不言而寓
https://www.businesswire.com/news/home/20211011005726/en/COVID-19-Cytokine-Storm-and-Coagulopathy-Markers-Controlled-With-Nichi-Glucan-Variants-The-First-of-Its-Kind-Report-in-a-Clinical-Study
Nichi Glucan and Nichi Glucan REFIX Beta 1,3-1,6 glucans, produced by AFO-202 and N-163 strains of Black Yeast Aureobasidium Pullulans are unique from other Beta glucans, being produced as an exo-polysaccharide with higher purity and unique structure, which are considered as reasons for their multiple benefits to human health, including the one reported in this clinical study in Covid-19 patients. (Graphic: Business Wire)
TOKYO--(BUSINESS WIRE)--Cytokine storm and coagulopathy, the major life-threatening complications of COVID-19, whose biomarkers Interleukin-6 and D-Dimer were under control with consumption of two variants of Nichi Glucan food supplements from Japan in a pilot study. Immune parameters like ratios of neutrophil to lymphocyte (NLR), lymphocyte to c-reactive protein (LCR) and leucocyte to c-reactive protein (LeCR) were advantageous, along with CD4 and CD8 levels, in those who consumed Nichi Glucans than, those who didn’t, as published in Biomedicine and Pharmacotherapy, a peer reviewed journal (https://www.sciencedirect.com/science/article/pii/S0753332221010271).
你所提到的VC和葡聚糖治新冠的提法，可能源於這篇小綜述。目前為止，沒看到任何臨床數據支持這個假設。
https://biomedres.us/pdfs/BJSTR.MS.ID.005431.pdf
Indeed, not all yeast glucans act the same because of the growth conditions and this might be also a key factor in the immunomodulation process. Besides the strain, brewery yeast β -glucan has a different pattern than those found in baker’s yeast and it seems to be well tolerated [36]. Nor such combinations between yeast glucan, vitamin C and resveratrol are neglected so a significant synergistic effect exists in order to boost the antibody production [37].……………
Taking together, bioactive compound exerts a great antiviral activity and previous studies clearly demonstrate its effectiveness in viral infections at the stage of viral entry, thus, it is necessary to perform further clinical trials and find the best combination which is suitable in the treatment of COVID-19.
